🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Early Screening Cohort Study of Multiple Gastrointestinal Tumors

Recruitingn/aAges 40 Years - 75 YearsAllShandong Cancer Hospital and Institute
NCT07106424 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Gastrointestinal tumors, including esophageal cancer, gastric cancer, and colorectal cancer, are among the most common and highly prevalent malignant tumors in Shandong Province. Currently, most patients seek medical attention only after clinical symptoms appear, by which time the disease has already reached an intermediate or advanced stage. This leads to increased treatment costs and poorer therapeutic outcomes. Early detection and intervention through screening are effective measures to improve the cure rate of gastrointestinal tumors and reduce their incidence and mortality rates. This project leverages the Shandong Province Tumor Screening and Early Diagnosis \& Treatment Platform and is based on the ongoing Shandong Gastrointestinal Cancer Screening Cohort. It aims to collect 4,000 plasma samples from individuals undergoing simultaneous screening for esophageal, gastric, and color

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * gastrointestinal cancer screening population * age 40-75 * no prior history of tumors Exclusion Criteria: * Severe heart disease, heart failure; * Severe respiratory disease, dyspnea, continuous asthma, or those with serious brain diseases; * Severe spinal deformity, or patients with aneurysms; * Physically weak and unable to tolerate endoscopy, or those who have difficulty remaining calm and self-controlled; * Acute corrosive inflammation of the gastrointestinal tract, or those suspected of having a gastrointestinal perforation; * Large amounts of ascites, severe abdominal distension, or severe esophageal varices; * Those with a tendency to bleed (abnormal coagulation function), or those taking anticoagulant medications. The latter must discontinue the medication for one week and have normal coagulation function before undergoing endoscopy; * Pregnant women; * Those with a history of iodine allergy, etc. * Patients who have been diagnosed with tumors or have a history of prior tumors.
💊

What it tests

  • Not listed
📍

Where

1 site
Affiliated Cancer Hospital of Shandong First Medical University
Jinan, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy